Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas.

Margaret Locke Nina Kohn Nagashree Seetharamu

Published in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2023)

Keyphrases

squamous cell
low dose
locally advanced
phase ii study
squamous cell carcinoma
open label
small cell lung cancer
rectal cancer
high dose
high grade
metastatic colorectal cancer
liver metastases
radiation therapy
phase iii
randomized controlled trial
clinical trial
double blind
wild type
study protocol